These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20919829)

  • 21. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth.
    Padi SKR; Singh N; Bearss JJ; Olive V; Song JH; Cardó-Vila M; Kraft AS; Okumura K
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20505-20510. PubMed ID: 31548394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of pim1 imposes a hyperadhesive phenotype on endothelial cells.
    Walpen T; Peier M; Haas E; Kalus I; Schwaller J; Battegay E; Humar R
    Cell Physiol Biochem; 2012; 30(4):1083-96. PubMed ID: 23202547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear PIM1 confers resistance to rapamycin-impaired endothelial proliferation.
    Walpen T; Kalus I; Schwaller J; Peier MA; Battegay EJ; Humar R
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):24-30. PubMed ID: 23131564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.
    Anjum F; Mohammad T; Almalki AA; Akhtar O; Abdullaev B; Hassan MI
    OMICS; 2021 Sep; 25(9):580-590. PubMed ID: 34448628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIM1 is a Poor Prognostic Factor for and Potential Therapeutic Target in Serous Carcinoma of the Endometrium.
    Takeuchi H; Miyamoto T; Fuseya C; Asaka R; Ida K; Ono M; Tanaka Y; Shinagawa M; Ando H; Asaka S; Shiozawa T
    Int J Gynecol Pathol; 2023 May; 42(3):282-292. PubMed ID: 35443252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
    Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
    Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
    Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
    Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
    Xu Z; Gwin KA; Li Y; Medina KL
    BMC Immunol; 2016 Jun; 17(1):16. PubMed ID: 27287229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression.
    Iadevaia V; Caldarola S; Biondini L; Gismondi A; Karlsson S; Dianzani I; Loreni F
    Oncogene; 2010 Oct; 29(40):5490-9. PubMed ID: 20639905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach.
    Shafie A; Khan S; Batra S; Anjum F; Mohammad T; Alam S; Yadav DK; Islam A; Hassan MI
    PLoS One; 2021; 16(10):e0258929. PubMed ID: 34679086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Pim family of protein kinases: structure, functions and roles in hematopoietic malignancies].
    Zhukova IuN; Alekseeva MG; Zakharevich NV; Shtil' AA; Danilenko VN
    Mol Biol (Mosk); 2011; 45(5):755-64. PubMed ID: 22393773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.
    Kreuz S; Holmes KB; Tooze RM; Lefevre PF
    Mol Cancer; 2015 Dec; 14():205. PubMed ID: 26643319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of pim1 kinase in complex with a pyrido[4,3-d]pyrimidine derivative suggests a unique binding mode.
    Lee SJ; Han BG; Cho JW; Choi JS; Lee J; Song HJ; Koh JS; Lee BI
    PLoS One; 2013; 8(7):e70358. PubMed ID: 23936194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIM1 Promotes Survival of Cardiomyocytes by Upregulating c-Kit Protein Expression.
    Ebeid DE; Firouzi F; Esquer CY; Navarrete JM; Wang BJ; Gude NA; Sussman MA
    Cells; 2020 Aug; 9(9):. PubMed ID: 32878131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
    Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.
    Blanco FF; Jimbo M; Wulfkuhle J; Gallagher I; Deng J; Enyenihi L; Meisner-Kober N; Londin E; Rigoutsos I; Sawicki JA; Risbud MV; Witkiewicz AK; McCue PA; Jiang W; Rui H; Yeo CJ; Petricoin E; Winter JM; Brody JR
    Oncogene; 2016 May; 35(19):2529-41. PubMed ID: 26387536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
    Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
    Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.